Greater China Digest: Novo Holdings acquires Ritedose; GL Ventures backs UWinTech

Source: Volodymyr Hryshchenko/Unsplash

Novo Holdings has agreed to acquire US pharmaceutical manufacturer Ritedose Corporation from Hong Kong-based AGIC Capital and China’s Humanwell Healthcare while UWinTech has secured $28 million in its Series C round. 

Novo Holdings acquires Ritedose from AGIC, Humanwell

Life science investor Novo Holdings, part of the Novo Nordisk Foundation, has agreed to acquire US pharmaceutical manufacturer Ritedose Corporation from Hong Kong-based AGIC Capital and China’s Humanwell Healthcare. 

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter